Jiao E. Wu
Kunming, 650118, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
EGFR G719X + S768I co-mutations in NSCLC: genomic landscape and differential responses to EGFR-TKIs in a large real-world cohort.
Journal: BMC cancer
Published: December 15, 2025
CDK9 targeting PROTAC L055 inhibits ERα-positive breast cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 12, 2024
Factors influencing the interpretation of immunohistochemical results in breast cancer with low expression of estrogen receptor
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: January 05, 2024
Advances in immune checkpoint inhibitors induced-cardiotoxicity.
Journal: Frontiers in immunology
Published: December 23, 2022
RNF126-Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple-Negative Breast Cancer to Radiotherapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 06, 2022
KLF5-induced lncRNA IGFL2-AS1 promotes basal-like breast cancer cell growth and survival by upregulating the expression of IGFL1.
Journal: Cancer letters
Published: February 05, 2021
Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer.
Journal: Frontiers in pharmacology
Published: November 12, 2020
Meta-analysis of the Efficacy and Tolerability of Immune Checkpoint Inhibitors Combined With Chemotherapy in First-line Treatment of Small Cell Lung Cancer.
Journal: Clinical therapeutics
Published: September 30, 2020
Cyst(e)ine in nutrition formulation promotes colon cancer growth and chemoresistance by activating mTORC1 and scavenging ROS.
Journal: Signal transduction and targeted therapy
Published: September 25, 2020
CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis.
Journal: Acta biochimica et biophysica Sinica
Published: October 31, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026